Patient-Reported Outcomes Through 5 Years for Active Surveillance, Surgery, Brachytherapy, or External Beam Radiation With or Without Androgen Deprivation Therapy for Localized Prostate Cancer.

MLA

Hoffman, Karen E., et al. “Patient-Reported Outcomes Through 5 Years for Active Surveillance, Surgery, Brachytherapy, or External Beam Radiation With or Without Androgen Deprivation Therapy for Localized Prostate Cancer.” JAMA: Journal of the American Medical Association, vol. 323, no. 2, Jan. 2020, pp. 149–63. EBSCOhost, https://doi.org/10.1001/jama.2019.20675.

APA

Hoffman, K. E., Penson, D. F., Zhao, Z., Huang, L.-C., Conwill, R., Laviana, A. A., Joyce, D. D., Luckenbaugh, A. N., Goodman, M., Hamilton, A. S., Wu, X.-C., Paddock, L. E., Stroup, A., Cooperberg, M. R., Hashibe, M., O’Neil, B. B., Kaplan, S. H., Greenfield, S., Koyama, T., & Barocas, D. A. (2020). Patient-Reported Outcomes Through 5 Years for Active Surveillance, Surgery, Brachytherapy, or External Beam Radiation With or Without Androgen Deprivation Therapy for Localized Prostate Cancer. JAMA: Journal of the American Medical Association, 323(2), 149–163. https://doi.org/10.1001/jama.2019.20675

Chicago

Hoffman, Karen E., David F. Penson, Zhiguo Zhao, Li-Ching Huang, Ralph Conwill, Aaron A. Laviana, Daniel D. Joyce, et al. 2020. “Patient-Reported Outcomes Through 5 Years for Active Surveillance, Surgery, Brachytherapy, or External Beam Radiation With or Without Androgen Deprivation Therapy for Localized Prostate Cancer.” JAMA: Journal of the American Medical Association 323 (2): 149–63. doi:10.1001/jama.2019.20675.